A pill to treat COVID-19 appears to be the country's best hope, outside of vaccines and strong public health measures, to keep hospitals from being overrun with cases of the virus now and in the future, doctors say.
B.C. has requested a cumulative threshold of 4.5 grams for opioids, cocaine and methamphetamine, but the federal government is mulling a 2.5-gram cumulative threshold, decriminalization advocates say.
Experts say rapid antigen tests are emerging as an important tool as Canada's pandemic strategy shifts from public health vigilance to an emphasis on personal responsibility.
The change will spark a surge in travel bookings both into and out of the country, according to the Tourism Industry Association of Canada, although it's not likely to reach pre-pandemic levels yet.
Canada may not be able to donate millions of doses of the only COVID-19 vaccine made in the country because the World Health Organization is leaning against granting it an emergency-use licence.
An association of window-blind makers is warning of a steep financial hit to companies, and potentially the loss of thousands of jobs, in a few weeks unless Health Canada delays enacting a new set of safety rules.
Known as Covifenz, the vaccine was developed by Medicago, a biotechnology company based in Quebec City that uses a plant host to make virus−like particles which help the body’s immune system make antibodies.
The Canadian government has signed an agreement with pharmaceutical company AstraZeneca to procure 100,000 doses of a COVID−19 antibody therapy that’s still under review by Health Canada.
The exemption, passed by order in council last month, is due to the "urgent public health necessity" of the supplies they are transporting, Health Canada states.